USJ Stock Overview
Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
USANA Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$34.00 |
| 52 Week High | US$49.00 |
| 52 Week Low | US$31.40 |
| Beta | 0.89 |
| 11 Month Change | 7.59% |
| 3 Month Change | -5.56% |
| 1 Year Change | -19.81% |
| 33 Year Change | -60.23% |
| 5 Year Change | -49.63% |
| Change since IPO | 106.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| USJ | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | -2.2% |
| 1Y | -19.8% | 0.2% | 13.3% |
Return vs Industry: USJ underperformed the German Personal Products industry which returned 0.2% over the past year.
Return vs Market: USJ underperformed the German Market which returned 13.3% over the past year.
Price Volatility
| USJ volatility | |
|---|---|
| USJ Average Weekly Movement | 4.7% |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: USJ has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: USJ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,800 | Jim Brown | www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
USANA Health Sciences, Inc. Fundamentals Summary
| USJ fundamental statistics | |
|---|---|
| Market cap | €663.91m |
| Earnings (TTM) | €49.95m |
| Revenue (TTM) | €792.33m |
13.3x
P/E Ratio0.8x
P/S RatioIs USJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USJ income statement (TTM) | |
|---|---|
| Revenue | US$861.97m |
| Cost of Revenue | US$164.98m |
| Gross Profit | US$697.00m |
| Other Expenses | US$642.65m |
| Earnings | US$54.34m |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.85 |
| Gross Margin | 80.86% |
| Net Profit Margin | 6.30% |
| Debt/Equity Ratio | 0% |
How did USJ perform over the long term?
See historical performance and comparison